In its latest 13F filing, Viking Global, managed by Andreas Halvorsen, revealed its equity portfolio as held at the end of the fourth quarter of 2013. The value of Viking Global’s equity portfolio amounted to $21.42 billion, up from $18.11 billion disclosed at the end of the third quarter of 2013.
In this piece, we have picked top five holdings in terms of value that the fund has held in its equity portfolio at the end of 2013.
The first one is Thermo Fisher Scientific Inc. (NYSE:TMO), in which Viking Global disclosed holding 10.38 million shares, with a reported value of around $1.16 billion. The fund held 10.57 million shares at the end of the third quarter.
The second position is held by Twenty-First Century Fox Inc (NASDAQ:FOXA), in which the fund reported a $1.06 billion stake. The fund holds 30.09 million shares of the company, up from 24.52 million shares.
In Facebook Inc (NASDAQ:FB), Viking Global boosted its stake to 18.30 million shares, worth $1.0 billion, from 4.43 million shares. The company’s revenue for the fourth quarter of 2013 totaled $2.59 billion, an increase of 63%, compared with $1.59 billion in the fourth quarter of 2012.
On the fourth place is Valeant Pharmaceuticals Intl Inc (NYSE:VRX), in which the fund currently holds 8.33 million shares, with a reported value of $977.83 million. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics.
The fifth most valuable holding of Viking Global is Capital One Financial Corp. (NYSE:COF), a financial holding company that offers a broad spectrum of financial products and services to consumers, small businesses and commercial clients through a variety of channels. The fund disclosed owning 12.64 million shares, with a reported value of $968.02 million.